These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18701618)

  • 21. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
    McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC
    J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the interaction between inactivation gating and Dd-sotalol block of HERG.
    Numaguchi H; Mullins FM; Johnson JP; Johns DC; Po SS; Yang IC; Tomaselli GF; Balser JR
    Circ Res; 2000 Nov; 87(11):1012-8. PubMed ID: 11090546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
    Chapman H; Pasternack M
    Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Link between Inactivation and High-Affinity Block of hERG1 Channels.
    Wu W; Gardner A; Sanguinetti MC
    Mol Pharmacol; 2015 Jun; 87(6):1042-50. PubMed ID: 25855787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state.
    Johnson JP; Balser JR; Bennett PB
    Biophys J; 1999 Nov; 77(5):2534-41. PubMed ID: 10545354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.
    Scholz EP; Alter M; Zitron E; Kiesecker C; Kathöfer S; Thomas D; Kreye VA; Kreuzer J; Becker R; Katus HA; Greten J; Karle CA
    Toxicol Lett; 2006 Aug; 165(2):156-66. PubMed ID: 16647228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HERG channels by the local anaesthetic articaine.
    Siebrands CC; Friederich P
    Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.
    Duncan RS; Ridley JM; Dempsey CE; Leishman DJ; Leaney JL; Hancox JC; Witchel HJ
    Biochem Biophys Res Commun; 2006 Mar; 341(2):500-6. PubMed ID: 16446155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
    Cordeiro JM; Brugada R; Wu YS; Hong K; Dumaine R
    Cardiovasc Res; 2005 Aug; 67(3):498-509. PubMed ID: 16039272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.
    Lin J; Guo J; Gang H; Wojciechowski P; Wigle JT; Zhang S
    Mol Pharmacol; 2005 Sep; 68(3):855-65. PubMed ID: 15967876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels.
    Clarke CE; Hill AP; Zhao J; Kondo M; Subbiah RN; Campbell TJ; Vandenberg JI
    J Physiol; 2006 Jun; 573(Pt 2):291-304. PubMed ID: 16556651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
    Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
    Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN
    Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs.
    Crumb W; Llorca PM; Lancon C; Thomas GP; Garay RP; Hameg A
    Eur J Pharmacol; 2006 Feb; 532(3):270-8. PubMed ID: 16494862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of sophocarpine on HERG K+ channels].
    Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
    Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A binary QSAR model for classification of hERG potassium channel blockers.
    Thai KM; Ecker GF
    Bioorg Med Chem; 2008 Apr; 16(7):4107-19. PubMed ID: 18243713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety.
    Gintant GA; Su Z; Martin RL; Cox BF
    Toxicol Pathol; 2006; 34(1):81-90. PubMed ID: 16507548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants of hERG channel block by terfenadine and cisapride.
    Kamiya K; Niwa R; Morishima M; Honjo H; Sanguinetti MC
    J Pharmacol Sci; 2008 Nov; 108(3):301-7. PubMed ID: 18987434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hERG potassium channel and hERG screening for drug-induced torsades de pointes.
    Hancox JC; McPate MJ; El Harchi A; Zhang YH
    Pharmacol Ther; 2008 Aug; 119(2):118-32. PubMed ID: 18616963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.